Click on the links below to access the satellite invitations. The following satellites are listed in alphabetical order (by company).
Achieving new standards in bone metastases treatment
Personalising medicine for GI cancers
HER2-targeted therapy for metastatic breast cancer: A multidisciplinary approach
New evidence, new standards? Redefining treatment selection in mRCC
Managing GI malignancies with targeted therapeutics; focus on NET, GIST, and HCC
Targeting advanced breast cancer at the molecular level – translating emerging data into clinical practice
Timely interventions in metastatic RCC: Treatment choices in an intricate landscape
Beyond convention: New perspectives in NSCLC
Clinical advances in HER2-positive breast cancer: Overcoming challenges with patients in mind
Individualised treatment strategies to maximise survival in mCRC
Integrating bevacizumab into clinical practice in ovarian cancer
Personalising therapy in metastatic melanoma
Turning today’s challenges in tomorrow’s success
Please note: The European Society for Medical Oncology (ESMO) does not endorse any of the companies, or their products/services, that have sponsored these links.